IP Verse

Thyroid Hormone Receptor Agonists And Uses Thereof

Patent No. EP3807267 (titled "Thyroid Hormone Receptor Agonists And Uses Thereof") was filed by Fronthera Pharmaceuticals on May 28, 2019. The application was issued on Mar 19, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEDec 19, 2025ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3807267

FRONTHERA PHARMACEUTICALS
Application Number
EP19819262A
Filing Date
May 28, 2019
Status
Granted And Under Opposition
Feb 14, 2025
Publication Date
Mar 19, 2025
External Links
Slate, Register , Google Patents